Heart Failure (HF) is a multi-faceted and life-threatening syndrome characterized by
significant morbidity and mortality, poor functional capacity and quality of life, and high costs …

Left ventricular ejection fraction (EF) remains the major parameter for diagnosis,
phenotyping, prognosis and treatment decisions in heart failure. The 2016 ESC heart failure …

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of 64
million people globally. Although the incidence of HF has stabilised worldwide and seems to …

Objective Digital healthcare systems could provide insights into the global prevalence of
heart failure (HF). We designed the CardioRenal and Metabolic disease (CaReMe) HF study …

Aims The aim of this analysis was to provide data on the overall comorbidity burden, both
cardiovascular (CV) and non‐CV, in a large real‐world heart failure (HF) population across …

Heart failure (HF) is a long‐term clinical syndrome, with increasing prevalence and
considerable healthcare costs that are further expected to increase dramatically. Despite …

Aims To evaluate the prevalence and associations of non-cardiac comorbidities (NCCs) with
in-hospital and post-discharge outcomes in acute heart failure (AHF) across the ejection …

Aims Renin–angiotensin–aldosterone system inhibitors (RAASi) improve outcomes in
cardiorenal disease but concerns have been raised over increased risk of incident …

Metabolic comorbidities are common in patients with cardiorenal disease; they can cause
atherosclerotic cardiovascular disease (ASCVD), speed progression, and adversely affect …

Abstract Aims The Heart Failure Association of the European Society of Cardiology has
recently proposed to optimize guideline‐directed medical treatments according to patient's …